Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases.
J Immunother Cancer. 2023 Aug;11(8):e007240. doi: 10.1136/jitc-2023-007240.
J Immunother Cancer. 2023.
PMID: 37586773
Free PMC article.
Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance.
Schoenfeld DA, Merkin RD, Moutafi M, Martinez S, Adeniran A, Kumar D, Jilaveanu L, Hurwitz M, Rimm DL, Kluger HM.
Schoenfeld DA, et al. Among authors: merkin rd.
Front Oncol. 2022 Oct 13;12:990367. doi: 10.3389/fonc.2022.990367. eCollection 2022.
Front Oncol. 2022.
PMID: 36313654
Free PMC article.
Item in Clipboard
ScRNA-seq defines dynamic T-cell subsets in longitudinal colon and peripheral blood samples in immune checkpoint inhibitor-induced colitis.
Mann JE, Lucca L, Austin MR, Merkin RD, Robert ME, Al Bawardy B, Raddassi K, Aizenbud L, Joshi NS, Hafler DA, Abraham C, Herold KC, Kluger HM.
Mann JE, et al. Among authors: merkin rd.
J Immunother Cancer. 2023 Aug;11(8):e007358. doi: 10.1136/jitc-2023-007358.
J Immunother Cancer. 2023.
PMID: 37586769
Free PMC article.
Item in Clipboard
Management of patients with brain metastases from NSCLC without a genetic driver alteration: upfront radiotherapy or immunotherapy?
Merkin RD, Chiang VL, Goldberg SB.
Merkin RD, et al.
Ther Adv Med Oncol. 2023 May 29;15:17588359231175438. doi: 10.1177/17588359231175438. eCollection 2023.
Ther Adv Med Oncol. 2023.
PMID: 37275964
Free PMC article.
Review.
Item in Clipboard
Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
Merkin RD, Vanner EA, Romeiser JL, Shroyer ALW, Escobar-Hoyos LF, Li J, Powers RS, Burke S, Shroyer KR.
Merkin RD, et al.
Hum Pathol. 2017 Apr;62:23-32. doi: 10.1016/j.humpath.2016.10.006. Epub 2016 Nov 2.
Hum Pathol. 2017.
PMID: 27816721
Item in Clipboard
99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer.
Hillier SM, Maresca KP, Lu G, Merkin RD, Marquis JC, Zimmerman CN, Eckelman WC, Joyal JL, Babich JW.
Hillier SM, et al. Among authors: merkin rd.
J Nucl Med. 2013 Aug;54(8):1369-76. doi: 10.2967/jnumed.112.116624. Epub 2013 Jun 3.
J Nucl Med. 2013.
PMID: 23733925
Free article.
Item in Clipboard
Cite
Cite